Cancer Family
Leukemia
CI-CAN-00000215Explore in graph →
HematologicTop-level1,769 active trials42 approved drugs708 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000215Explore in graph →
Clinical trials
8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,348)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02991638 | Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers | unknown | Phase 3 | 62 | The University of Hong KongOTHER | 1 | Apr 12, 2018 | clinicaltrials |
| NCT03256071 | Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT | unknown | Phase 2 / Phase 3 | 90 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 |
| Aug 21, 2017 |
| clinicaltrials |
| NCT01226303 | Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia | unknown | Phase 3 | 300 | Associazione Italiana Ematologia Oncologia PediatricaOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT02979548 | Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy | unknown | Phase 3 | 116 | Dr Atul SharmaOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT03027739 | CART-19 Cells For MRD Positive CD19+ ALL(CCFMPCA) | unknown | Phase 2 / Phase 3 | 20 | Fujian Medical UniversityOTHER | 1 | Jan 23, 2017 | clinicaltrials |
| NCT01828489 | Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years(AML2012) | unknown | Phase 3 | 300 | Vastra Gotaland RegionOTHER_GOV | 9 | Jan 10, 2017 | clinicaltrials |
| NCT02985372 | Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia | unknown | Phase 3 | 30 | Chunyan JiOTHER | 0 | Dec 7, 2016 | clinicaltrials |
| NCT01484171 | HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia | unknown | Phase 3 | 50 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT02171117 | Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia(IMCG-EAML) | unknown | Phase 3 | 196 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT02757040 | Combination of Ibrutinib and As2O3 in the Treatment of CLL | unknown | Phase 3 | 70 | Peking University People's HospitalOTHER | 0 | Apr 29, 2016 | clinicaltrials |
| NCT02244658 | Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia | unknown | Phase 3 | 80 | Shandong UniversityOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT01067300 | A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission | unknown | Phase 3 | 198 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL(ALL-SCT-BFMi) | unknown | Phase 3 | 405 | St. Anna KinderkrebsforschungOTHER | 11 | Jun 26, 2015 | clinicaltrials |
| NCT01423747 | Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia | unknown | Phase 3 | 400 | St. Anna KinderkrebsforschungOTHER | 2 | Jun 26, 2015 | clinicaltrials |
| NCT02427919 | Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML(DeGREE) | unknown | Phase 2 / Phase 3 | 56 | Seoul St. Mary's HospitalOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT01800643 | Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | unknown | Phase 2 / Phase 3 | 100 | Hospital Israelita Albert EinsteinOTHER | 1 | Dec 3, 2014 | clinicaltrials |
| NCT02270307 | MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis(MSC-CY) | unknown | Phase 2 / Phase 3 | 40 | National Research Center for Hematology, RussiaNETWORK | 1 | Oct 21, 2014 | clinicaltrials |
| NCT02070523 | Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: | unknown | Phase 3 | 200 | Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd.OTHER | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00378365 | Acute Promyelocytic Leukemia 2006 (APL) | unknown | Phase 3 | 800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT02072785 | Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia(LY01609) | unknown | Phase 3 | 480 | Nanjing Luye Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 3, 2014 | clinicaltrials |
| NCT02072811 | Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia(PALG-AML2012) | unknown | Phase 3 | 400 | dr hab. n. med. Agnieszka WierzbowskaOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT01400074 | Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib(RE-NICE) | unknown | Phase 3 | 100 | Seoul St. Mary's HospitalOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00482716 | Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer | unknown | Phase 3 | 80 | St. Bartholomew's HospitalOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00454168 | Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission | unknown | Phase 3 | 244 | The Vaccine CompanyINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00002658 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | unknown | Phase 3 | 2,000 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002869 | Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | unknown | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00020865 | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia | unknown | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00025402 | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | unknown | Phase 3 | 1,000 | III. Medizinische Klinik MannheimOTHER | 5 | Dec 18, 2013 | clinicaltrials |
| NCT00003437 | Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | unknown | Phase 3 | 1,800 | Medical Research CouncilOTHER_GOV | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00006045 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | unknown | Phase 3 | — | Facet BiotechINDUSTRY | 7 | Nov 6, 2013 | clinicaltrials |
| NCT00002499 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia | unknown | Phase 2 / Phase 3 | — | Grupo Argentino de Tratamiento de la Leucemia AgudaOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00002701 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | unknown | Phase 3 | 750 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 20, 2013 | clinicaltrials |
| NCT00003602 | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | unknown | Phase 3 | 400 | Riverside Haematology GroupOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00047268 | Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome | unknown | Phase 3 | — | European Working Group of MDS in ChildhoodOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00002771 | Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | unknown | Phase 3 | 750 | German CML Study GroupOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01809392 | Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | unknown | Phase 2 / Phase 3 | 15 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT01766375 | the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient(IDBUCY) | unknown | Phase 3 | 200 | Guangxi Medical UniversityOTHER | 1 | Jan 11, 2013 | clinicaltrials |
| NCT01678430 | A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment(RIAltO) | unknown | Phase 3 | 670 | University of LiverpoolOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT01615757 | Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation(Ara-c) | unknown | Phase 3 | 180 | All India Institute of Medical SciencesOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT01670812 | Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia | unknown | Phase 3 | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 22, 2012 | clinicaltrials |
| NCT01657955 | Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia(CLL) | unknown | Phase 3 | 96 | Shandong Lanjin Pharmaceuticals Co.,LtdINDUSTRY | 1 | Aug 6, 2012 | clinicaltrials |
| NCT00091234 | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia(AML-19) | unknown | Phase 2 / Phase 3 | 279 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 24, 2012 | clinicaltrials |
| NCT01633099 | Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients | unknown | Phase 3 | 46 | Jianxiang WangUNKNOWN | 0 | Jul 6, 2012 | clinicaltrials |
| NCT01015742 | Unrelated Double Umbilical Cord Blood Units Transplantation | unknown | Phase 2 / Phase 3 | 10 | Tehran University of Medical SciencesOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00111345 | Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents | unknown | Phase 2 / Phase 3 | 550 | University Hospital MuensterOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT01414231 | Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a(OSHO#061) | unknown | Phase 3 | 850 | University of LeipzigOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00003728 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | unknown | Phase 3 | 1,500 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jan 21, 2011 | clinicaltrials |
| NCT00715637 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | unknown | Phase 3 | 420 | Antisoma ResearchINDUSTRY | 23 | Oct 13, 2010 | clinicaltrials |
| NCT01145846 | Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML)(AIvsAD) | unknown | Phase 3 | 316 | Cooperative Study Group A for HematologyNETWORK | 1 | Jun 17, 2010 | clinicaltrials |
| NCT00002926 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia | unknown | Phase 3 | 80 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | May 27, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Apr 12, 2018source: clinicaltrials